| PERIOD ENDING | 5-Apr-09 | 31-Dec-08 | 28-Sep-08 | 29-Jun-08 | | Total Revenue | 120,608 | 194,767 | 297,255 | 317,705 | | Cost of Revenue | 87,248 | 116,856 | 169,325 | 163,857 | | | Gross Profit | 33,360 | 77,911 | 127,930 | 153,848 | | | Operating Expenses | | Research Development | 47,198 | 52,189 | 52,969 | 56,154 | | Selling General and Administrative | 55,373 | 58,491 | 58,614 | 65,463 | | Non Recurring | 15,965 | 343,456 | 28,589 | 12,726 | | Others | 8,239 | 6,962 | 5,034 | 4,774 | | | | Total Operating Expenses | 126,775 | 461,098 | 145,206 | 139,117 | | | | Operating Income or Loss | (93,415) | (383,187) | (17,276) | 14,731 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 777 | 2,274 | 2,740 | 2,462 | | Earnings Before Interest And Taxes | (92,638) | (380,913) | (14,536) | 17,193 | | Interest Expense | 5,830 | 8,371 | 5,851 | 14 | | Income Before Tax | (98,468) | (389,284) | (20,387) | 17,179 | | Income Tax Expense | (7,800) | (693) | 3,070 | 6,100 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (90,668) | (388,591) | (23,457) | 11,079 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| 768 |
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (90,668) | (388,591) | (22,689) | 11,079 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($90,668) | ($388,591) | ($22,689) | $11,079 |
|
0.45% Nasdaq 
0.20%
Income Statement
